Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Allegiance Health
mi
from
Jackson, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois CancerCare - Kewanee Clinic
mi
from
Kewanee, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Fairfield Medical Center
mi
from
Lancaster, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
McLaren Greater Lansing
mi
from
Lansing, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
OhioHealth Marion General Hospital
mi
from
Marion, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Carle Physician Group-Mattoon/Charleston
mi
from
Mattoon, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Community Medical Hospital
mi
from
Missoula, MT
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
The Hospital of Central Connecticut
mi
from
New Britain, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Oncology Hematology Consultants
mi
from
Newark, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Licking Memorial Hospital
mi
from
Newark, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Newberg Medical Center
mi
from
Newberg, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
The Valley Hospital-Luckow Pavilion
mi
from
Paramus, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois CancerCare-Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Oakland
mi
from
Pontiac, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern Ohio Medical Center
mi
from
Portsmouth, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois CancerCare - Princeton
mi
from
Princeton, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Norris Cotton Cancer Center-North
mi
from
Saint Johnsbury, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Swedish Medical Center-First Hill
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Spartanburg
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
John Muir Medical Center-Walnut Creek
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford West Bloomfield Hospital
mi
from
West Bloomfield, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Wexford Health and Wellness Pavilion
mi
from
Wexford, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KS
Click here to add this to my saved trials
Thrombosis Clinical Trial
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Status: Enrolling, Phase III
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Thrombosis Clinical Trial
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Status: Enrolling, Phase III
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Thrombosis Clinical Trial
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Status: Enrolling, Phase III
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Thrombosis Clinical Trial
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Status: Enrolling, Phase III
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Thrombosis Clinical Trial
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Thrombosis Clinical Trial
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Iowa Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Thrombosis Clinical Trial
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Thrombosis Clinical Trial
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Status: Enrolling, Phase III
Updated: 12/31/1969
Mattel Children's Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Thrombosis Clinical Trial
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Thrombosis Clinical Trial
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Status: Enrolling, Phase III
Updated: 12/31/1969
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Posttraumatic Stress Disorder Clinical Trial
Improving Psychosocial Functioning in Older Veterans With PTSD
Status: Enrolling, Phase
Updated: 12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Phase 3 Alogliptin Pediatric Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Phase 3 Alogliptin Pediatric Study
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Phase 3 Alogliptin Pediatric Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Nemours Children's Specialty Care, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Phase 3 Alogliptin Pediatric Study
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Phase 3 Alogliptin Pediatric Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Phase 3 Alogliptin Pediatric Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Ochsner Baptist Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Autism Spectrum Disorder Clinical Trial
A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Pacific Institute of Medical Sciences
mi
from
Bothell, WA
Click here to add this to my saved trials
Autism Spectrum Disorder Clinical Trial
A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Autism Spectrum Disorder Clinical Trial
A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Autism Spectrum Disorder Clinical Trial
A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Harmonex Neuroscience Research
mi
from
Dothan, AL
Click here to add this to my saved trials
Autism Spectrum Disorder Clinical Trial
A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Autism Spectrum Disorder Clinical Trial
A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Southwest Autism Research and Resource Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Autism Spectrum Disorder Clinical Trial
A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Road Runner Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Beat AML Core Study
Status: Enrolling, Phase
Updated: 12/31/1969
UF Health Cancer Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Ankle and Hindfoot Arthrodesis Clinical Trial
Long-term Safety and Effectiveness of AUGMENT® Bone Graft Compared to Autologous Bone Graft
Status: Enrolling, Phase
Updated: 3/23/2018
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Ankle and Hindfoot Arthrodesis Clinical Trial
Long-term Safety and Effectiveness of AUGMENT® Bone Graft Compared to Autologous Bone Graft
Status: Enrolling, Phase
Updated: 3/23/2018
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Ankle and Hindfoot Arthrodesis Clinical Trial
Long-term Safety and Effectiveness of AUGMENT® Bone Graft Compared to Autologous Bone Graft
Status: Enrolling, Phase
Updated: 3/23/2018
Illinois Bone & Joint Institute
mi
from
Glenview, IL
Click here to add this to my saved trials
Ankle and Hindfoot Arthrodesis Clinical Trial
Long-term Safety and Effectiveness of AUGMENT® Bone Graft Compared to Autologous Bone Graft
Status: Enrolling, Phase
Updated: 3/23/2018
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Ankle and Hindfoot Arthrodesis Clinical Trial
Long-term Safety and Effectiveness of AUGMENT® Bone Graft Compared to Autologous Bone Graft
Status: Enrolling, Phase
Updated: 3/23/2018
The Center for Bone and Joint Surgery
mi
from
Royal Palm Beach, FL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Study of IACS-010759 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Musculoskeletal Clinical Trial
Postoperative Pain Control After Enucleation or Evisceration
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study to Determine Dose and Tolerability of CC-220 Monotherapy, in Combination With Dexamethasone, and in Combination With Dexamethasone and Daratumumab or Bortezomib in Subjects With Relapsed and Refractory Multiple Myeloma (MM)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study to Determine Dose and Tolerability of CC-220 Monotherapy, in Combination With Dexamethasone, and in Combination With Dexamethasone and Daratumumab or Bortezomib in Subjects With Relapsed and Refractory Multiple Myeloma (MM)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
New York Presbyterian Hospital- Weil Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study to Determine Dose and Tolerability of CC-220 Monotherapy, in Combination With Dexamethasone, and in Combination With Dexamethasone and Daratumumab or Bortezomib in Subjects With Relapsed and Refractory Multiple Myeloma (MM)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study to Determine Dose and Tolerability of CC-220 Monotherapy, in Combination With Dexamethasone, and in Combination With Dexamethasone and Daratumumab or Bortezomib in Subjects With Relapsed and Refractory Multiple Myeloma (MM)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Posterior Fossa Ependymoma (PFEPN) Clinical Trial
Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Neurology Clinical Trial
High-dose Erythropoietin for Asphyxia and Encephalopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Neurology Clinical Trial
High-dose Erythropoietin for Asphyxia and Encephalopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Neurology Clinical Trial
High-dose Erythropoietin for Asphyxia and Encephalopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Cook Children's Hospital
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Neurology Clinical Trial
High-dose Erythropoietin for Asphyxia and Encephalopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Neurology Clinical Trial
High-dose Erythropoietin for Asphyxia and Encephalopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Neurology Clinical Trial
High-dose Erythropoietin for Asphyxia and Encephalopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Intermountain Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Neurology Clinical Trial
High-dose Erythropoietin for Asphyxia and Encephalopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Methodist Children's Hospital
mi
from
San antonio, TX
Click here to add this to my saved trials
Neurology Clinical Trial
High-dose Erythropoietin for Asphyxia and Encephalopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Neurology Clinical Trial
High-dose Erythropoietin for Asphyxia and Encephalopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Neurology Clinical Trial
High-dose Erythropoietin for Asphyxia and Encephalopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Tuberous Sclerosis Complex Clinical Trial
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
Status: Enrolling, Phase II
Updated: 12/31/1969
Beaumont Children's Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Cocaine Dependence Clinical Trial
Theta-Burst Stimulation as a Treatment for Reducing Cocaine Use
Status: Enrolling, Phase IV
Updated: 12/31/1969
National Institute on Drug Abuse
mi
from
Baltimore, MD
Click here to add this to my saved trials
Autoimmune Pulmonary Alveolar Proteinosis Clinical Trial
Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis
Status: Enrolling, Phase I
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety Issues Clinical Trial
Using Emergency Manuals During Interprofessional Crisis Management: Are There Unintended Consequences?
Status: Enrolling
Updated: 12/29/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Mesothelioma Clinical Trial
Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Status: Enrolling, Phase II, III
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
Cardiothoracic & Vascular Surgeons
mi
from
Austin, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
Univeristy of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
Cedar Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
The Heart Hospital Baylor Plano
mi
from
Plano, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
University of Florida Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
Sentara Medical Group
mi
from
Norfolk, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
University of Louisville - Jewish Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Renal Impairment Clinical Trial
Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment
Status: Enrolling, Phase I
Updated: 12/31/1969
The American Institute of Research
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Status: Enrolling, Phase
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Status: Enrolling, Phase
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Status: Enrolling, Phase
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Status: Enrolling, Phase
Updated: 12/31/1969
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Status: Enrolling, Phase
Updated: 12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Status: Enrolling, Phase
Updated: 12/31/1969
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Status: Enrolling, Phase
Updated: 12/31/1969
Barrow Neurological Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Status: Enrolling, Phase
Updated: 12/31/1969
Howard University
mi
from
Washington DC,
Click here to add this to my saved trials
Hepatic Impairment Clinical Trial
Pharmacokinetics of Dabrafenib in Subjects With Hepatic Impairment
Status: Enrolling, Phase I
Updated: 12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials